Related Experiment Video
Updated: Jan 28, 2026
10:59
Visualizing the Conformational Dynamics of Membrane Receptors Using Single-Molecule FRET
Published on: August 17, 2022
3.8K
Conformational Dynamics in Insulin Receptor Kinase Reveals a Type III Allosteric Pocket
Biorxiv : the Preprint Server for Biology
|June 4, 2025
Summary
Researchers characterized a novel allosteric pocket in the insulin receptor kinase (IRK). This discovery aids in developing selective IRK inhibitors and understanding kinase regulation.
Area of Science:
- Biochemistry
- Structural Biology
- Pharmacology
Background:
- Allosteric modulation of kinases is crucial for selective drug design.
- Limited structural data exists for allosteric pockets in many human kinases.
Purpose of the Study:
- To comprehensively characterize a type III allosteric pocket in the insulin receptor kinase (IRK).
- To investigate the structural features and conformational dynamics of this pocket and its interaction with an inhibitor.
Main Methods:
- Microsecond-scale atomistic molecular dynamics (MD) simulations.
- Analysis of apo and inhibitor-bound IRK structures.
Main Results:
- Identified a type III allosteric
- back pocket
- in IRK, featuring a hydrophobic cleft and charge center.
- An IRK inhibitor stabilizes an inactive kinase conformation by promoting an
- out
- conformation of the α C-helix.
- Observed helical intermediate formation in the activation loop and a stable
- DFG-out
- conformation.
- Identified M1051 as a gatekeeper residue regulating inhibitor binding and α C-helix integrity.
Conclusions:
- The identified allosteric pocket is a viable target for developing selective IRK modulators.
- Findings inform therapeutic strategies for insulin receptor family-related diseases.
Related Concept Videos
01:58Cooperative Allosteric Transitions
8.7K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.7K
01:58Cooperative Allosteric Transitions
2.7K
2.7K
02:54Protein Kinases and Phosphatases
15.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.1K
01:26Receptor Tyrosine Kinases
18.4K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.4K
01:28Insulin: The Receptor and Signaling Pathways
3.0K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.0K
01:27Insulin Formulations: Types and Delivery
715
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
715